• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION NC EMERGE; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION NC EMERGE; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Model Number 7214
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 04/06/2021
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that shaft break occurred.The 85% stenosed target lesion was located in the moderately tortuous and moderately calcified left anterior descending artery.A 4.00mm x 20mm nc emerge balloon catheter was advanced for post-dilation.However, it was noted that the shaft was fractured.The device was removed fractured and the procedure was completed with another of the same device.No patient complications were reported.
 
Additional Manufacturer Narrative
Device evaluated by mfr.: the device was returned for analysis.The device was microscopically and visually examined.The hypotube of the device had numerous kinks.There was a separation 49.1cm from the strain relief.There was contrast in the inflation lumen and blood in the guidewire lumen.The balloon was tightly folded, and there was blood and contrast present in the folds.Inspection of the remainder of the device presented no other damage or irregularities.
 
Event or Problem Description
It was reported that shaft break occurred.The 85% stenosed target lesion was located in the moderately tortuous and moderately calcified left anterior descending artery.A 4.00mm x 20mm nc emerge balloon catheter was advanced for post-dilation.However, it was noted that the shaft was fractured.The device was removed fractured and the procedure was completed with another of the same device.No patient complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NC EMERGE
Common Device Name
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key11751074
Report Number2134265-2021-05200
Device Sequence Number11796993
Product Code LOX
UDI-Device Identifier08714729846697
UDI-Public08714729846697
Combination Product (Y/N)N
Initial Reporter StateTN
Initial Reporter CountryUS
PMA/510(K) Number
K141236
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 06/04/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date02/15/2023
Device Model Number7214
Device Catalogue Number7214
Device Lot Number0026807874
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/21/2021
Initial Date Received by Manufacturer 04/08/2021
Supplement Date Received by Manufacturer05/13/2021
Initial Report FDA Received Date04/30/2021
Supplement Report FDA Received Date06/04/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-